Arecor Therapeutics plc Stock Price

AIM:AREC Community·UK£24.0m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
2 Fair Values set on narratives written by author

Author Program NEW Create Narrative

AREC Share Price Performance

UK£0

-0.45 (-100.00%)

UK£0

-0.45 (-100.00%)

UK£0

Tue, 7 Jul 26

Share Pricen/a

AREC Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with low risk.

3 Risks

1 Reward

View Full Analysis

Arecor Therapeutics plc Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: 0.025
: 73.86%
: 54.38%
: 0%

View Full Analysis

About AREC

Founded: 2007
Employees: 33
CEO: Sarah Howell
WebsiteView website: arecor.com

Arecor Therapeutics plc, a clinical stage biotechnology company, develops therapeutics that address diabetes, obesity and other cardiometabolic diseases in the United Kingdom. The company’s lead therapeutic product is the AT278, a disruptor insulin which is designed to transform Automated Insulin Delivery (AID) systems to improve patient care for people living with diabetes. It also develops a novel oral delivery platform using a GLP-1 receptor agonist. Arecor Therapeutics plc was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.